USFDA inspects Andhra Pradesh facility of Laurus Labs’ arm

13 Dec 2023 Evaluate

Laurus Labs’ wholly owned subsidiary -- Laurus Synthesis (LSPL) has underwent the United States Food and Drug Administration (USFDA) inspection for the manufacturing facility in Parawada, Anakapalli, near Visakhapatnam, Andhra Pradesh. The inspection was conducted from December 4, 2023 to December 12, 2023. It has been issued a Form 483 with five observations and the Company will address the observations within stipulated timelines.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.


Laurus Labs Share Price

591.75 10.30 (1.77%)
18-Mar-2025 09:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1715.00
Dr. Reddys Lab 1158.75
Cipla 1508.00
Lupin 2011.65
Zydus Lifesciences 901.40
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...